Advanced Search
Contact | Corporate | Help

Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer

Sponsors:
  • Massachusetts General Hospital
  • Dana-Farber Cancer Institute
  • Beth Israel Deaconess Medical Center
  • Brigham and Women's Hospital
  • Genentech
  • Sanofi-Synthelabo
  • Hoffmann-La Roche
Phases:
  • Phase II
IndicationsAcronym:
  • Biliary Tract Cancer
  • Gallbladder Adenocarcinoma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Capecitabine
  • Drug: Oxaliplatin
  • Drug: Bevacizumab
  • Procedure: Radiation therapy
Enrollment:
26

Additional information about NCT00142480.


SourceSolution © 2008-2012